Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 7
Submit an article Journal homepage
361
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

Is CD30 a predictive biomarker for brentuximab vedotin?

Robert ChenDepartment of Hematology/HCT, City of Hope Medical Center, Duarte, CA, USACorrespondence[email protected]
Pages 1524-1525 | Received 25 Dec 2016, Accepted 26 Dec 2016, Published online: 06 Feb 2017
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Is CD30 a predictive biomarker for brentuximab vedotin?." Leukemia & Lymphoma, 58(7), pp. 1524–1525

Potential conflict of interest

Disclosure forms provided by the author is available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2017.1283687.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.